<Home — Psychoactive Plant Database



  Psychoactive Plant Database - Neuroactive Phytochemical Collection





Worldwide, there are plants known as psychoactive plants that naturally contain psychedelic active components. They have a high concentration of neuroprotective substances that can interact with the nervous system to produce psychedelic effects. Despite these plants' hazardous potential, recreational use of them is on the rise because of their psychoactive properties. Early neuroscience studies relied heavily on psychoactive plants and plant natural products (NPs), and both recreational and hazardous NPs have contributed significantly to the understanding of almost all neurotransmitter systems. Worldwide, there are many plants that contain psychoactive properties, and people have been using them for ages. Psychoactive plant compounds may significantly alter how people perceive the world.

 

 

1. Sci Rep. 2024 Oct 28;14(1):25791. doi: 10.1038/s41598-024-74972-7. Optimizing the extraction of essential oil yield from Pistacia lentiscus oleo-gum resin by superheated steam extraction using response surface methodology. Ayub MA(1), Iram I(2), Waseem R(2), Ayub I(3), Hussain A(4), Abid MA(2), Iqbal SZ(5). Author information: (1)Department of Chemistry, University of Sahiwal, Sahiwal, 57000, Pakistan. adnanayub@uosahiwal.edu.pk. (2)Department of Chemistry, University of Sahiwal, Sahiwal, 57000, Pakistan. (3)Department of Zoology, Government College University Faisalabad, Faisalabad, 38000, Pakistan. (4)Institute of Chemistry, University of Okara, Okara, Punjab, 56300, Pakistan. (5)Food Safety and Food Toxicology Lab, Department of Applied Chemistry, Government College University Faisalabad, Faisalabad, 38000, Pakistan. Pistacia lentiscus L. is an aromatic plant containing a significant percentage of essential oil (EO) used in fragrance, pharmaceuticals, cosmetics, and the food industry. The purpose of this work is focused on the optimization of Pistacia lentiscus L. oleo gum resin EO yield extracted by superheated steam extraction (SHSE) by response surface methodology, including extraction parameters of particle size (0. 5 - 1 mm), temperature (140-180 °C) and time (90-150 min). The optimum conditions for Pistacia lentiscus L. EO extracted by SHSE were found to be (particle size: 0.75 mm, time: 120 min and temperature: 160 ℃) which produced the highest EO yield of 5.7%. A regression model was developed, demonstrating a robust quadratic correlation with an R2 value of 0.9991, making it suitable for predictions. Furthermore, the yield of Pistacia lentiscus L. EO extracted by SHSE was compared with the conventional steam and hydro distillation techniques. The study revealed that SHSE yielded higher quantities of EO than other extraction methods. GC-MS analyzed the chemical composition of Pistacia lentiscus L. EO. The predominant compound of Pistacia lentiscus L. EO was determined to be α-pinene, while the other identified compounds include trans-verbenol, verbenol, cis-verbenone, camphene, β-myrcene, d-limonene, cymene, α-myrtenol, α-campholenal, α-copaene, and α-thujene, whose content differed according to different extraction techniques. Overall, superheated steam extraction is an efficient technique for extracting Pistacia lentiscus L. essential oil that enhances EO yield, requiring less time for extraction. © 2024. The Author(s). DOI: 10.1038/s41598-024-74972-7 PMCID: PMC11519484 PMID: 39468086 [Indexed for MEDLINE] Conflict of interest statement: The authors declare no competing interests. 2. Int J Microbiol. 2024 Oct 16;2024:8832448. doi: 10.1155/2024/8832448. eCollection 2024. Myrtenol's Effectiveness against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus: Targeting Antibiofilm and Antivirulence Properties. Makled AF(1), Labeeb AZ(1), Badr EAE(2), Abdelmaksoud AM(3), Elfiky SR(4), Amer AK(1), Sleem AS(1). Author information: (1)Department of Medical Microbiology and Immunology, Faculty of Medicine, Menoufa University, Shebin Al Kom, Egypt. (2)Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufa University, Shebin Al Kom, Egypt. (3)Department of Clinical Pathology, Faculty of Medicine, Menoufa University, Shebin Al Kom, Egypt. (4)Department of Clinical Pharmacology, Faculty of Medicine, Menoufa University, Shebin Al Kom, Egypt. The emergence of methicillin-resistant Staphylococcus aureus (MRSA) several years ago highlighted the challenge of multidrug-resistant infections, emphasizing the critical need for innovative treatment approaches. Myrtenol, known for its antibacterial and antibiofilm properties, holds promise as a potential treatment option. This study aimed to evaluate the effectiveness of myrtenol against MRSA. The collected MRSA isolates were assessed for antimicrobial susceptibility following the Clinical and Laboratory Standards Institute (CLSI) guidelines 2023. Biofilm formation by MRSA was evaluated using the tissue culture plate (TCP) technique. The minimal inhibitory concentration (MIC), minimal bactericidal concentration (MBC), and minimal biofilm inhibitory concentration (MBIC) of myrtenol against MRSA were determined both individually and in combination with antibiotics. Real-time PCR was employed to investigate the impact of myrtenol on the expression of virulence genes (sarA, agrA, and icaD) across the isolates. In this study, MRSA was identified in 90 out of 400 cases (22.5%) of hospital-acquired pathogens. Among the collected MRSA isolates, 53 out of 90 (59%) were found to produce biofilms. The MIC of myrtenol was comparable to the MBC across all tested isolates, they were almost the same. Combinations of myrtenol with most tested antibiotics exhibited synergistic effects exceeding 60%. Among the 53 biofilm-producing isolates, 45 isolates (85%) expressed the sarA gene, 49% expressed the agrA gene, and all biofilm-producing MRSA isolates (100%) expressed the icaD gene. A notable reduction in the relative quantity (RQ) values of virulence gene expression was observed after treatment with the MBIC of myrtenol across all tested isolates. Myrtenol demonstrated strong antimicrobial activity against MRSA, notably reducing the expression of key virulence genes linked to biofilm formation. This suggests its potential as a therapeutic agent for treating biofilm-associated MRSA infections. Copyright © 2024 Amal F. Makled et al. DOI: 10.1155/2024/8832448 PMCID: PMC11498983 PMID: 39445102 Conflict of interest statement: The authors declare that they have no conflicts of interest. 3. Front Vet Sci. 2024 Oct 3;11:1415232. doi: 10.3389/fvets.2024.1415232. eCollection 2024. Optimal fermentation of Shuanghuanglian and its effects on production performance of laying hens. Xu Y(#)(1), Yi S(#)(2), Xu X(1), Zhang M(1), Cui Y(3), Lan W(3), Li F(1), Kong X(1)(2)(3). Author information: (1)College of Life Science, Northeast Agricultural University, Harbin, China. (2)Hunan Provincial Key Laboratory of Animal Nutritional Physiology and Metabolic Process, National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, China. (3)School of Biology and Food Engineering, Fuyang Normal University, Fuyang, China. (#)Contributed equally BACKGROUND: Shuanghuanglian is a Chinese medicine composed of Honeysuckle Flower, Baical Skullcap Root, and Fructus Forsythiae. It has various effects, including anti-inflammatory, antibacterial, antiviral, and immunomodulatory effects. The fermented product of Shuanghuanglian can be used as an antibiotic alternative, as it has similar efficacy, which may improve the immunity, feed intake and utilization efficiency of laying hens, thus improving their production performance. The aim of this study was to optimize the fermentation conditions for Shuanghuanglian using single factor and response surface methodology, evaluate the chemical and microbial composition of the Shuanghuanglian fermentation liquor (SFL), and explore the effects of SFL on the production performance of laying hens. METHODS: A total of 288 Xinyang black-feather laying hens (50 week-old) were randomly allocated to four treatments with nine replicates, each replicate containing eight hens, for a total of 37 days trial (including a 7-day adaptation period). The treatments included a control group (0% SFL in drinking water) and drinking water supplemented with 0.3, 0.5, or 0.7% SFL. RESULTS: The fermentation optimization conditions for Shuanghuanglian were selected as a solid-to-liquid ratio at 1:7, 3% inoculation quantity, fermentation temperature at 28°C for 5 days, initial pH of 7, 60 mesh (sieved), and rotation speed of 150 r/min. Various bioactive compounds, such as myrtenol, 2-hexyn-1-ol, arsenous acid tris(trimethylsilyl) ester, 3(10)-caren-4-ol, and oxime-, methoxy-phenyl, were detected in SFL. The most abundant bacterial phyla in SFL were Proteobacteria and Firmicutes, with Acinetobacter being the most abundant genus. The most abundant fungal phyla were Phragmoplastophyta and Magnoliophyta. The 0.5 and 0.7% SFL supplementation in water increased egg weight and laying rate, while decreasing the feed-to-egg ratio of laying hens compared with the control group (p < 0.05). Additionally, 0.3, 0.5, and 0.7% SFL supplementation in water increased (p < 0.05) the Haugh unit, but there were no significant differences (p > 0.05) in albumen height, egg shape index, egg thickness, and yolk color of the eggs. CONCLUSION: Supplementation of SFL under optimized conditions had a positive impact on the production performance of laying hens, especially when the supplementation amount reached 0.5%. This study provides a theoretical basis for the application of Shuanghuanglian in the commercial egg industry. Copyright © 2024 Xu, Yi, Xu, Zhang, Cui, Lan, Li and Kong. DOI: 10.3389/fvets.2024.1415232 PMCID: PMC11483451 PMID: 39421831 Conflict of interest statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision. 4. Chem Biol Drug Des. 2024 Sep;104(3):e14633. doi: 10.1111/cbdd.14633. Myrtenol-Loaded Fatty Acid Nanocarriers Protect Rat Brains Against Ischemia-Reperfusion Injury: Antioxidant and Anti-Inflammatory Effects. Karimi Afshar S(1)(2), Rostamzadeh F(2), Bigdeli MR(1)(3), Mortazavi Moghadam F(4). Author information: (1)Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran. (2)Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. (3)Institute for Cognitive and Brain Science, Shahid Beheshti University, Tehran, Iran. (4)Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. This research investigated the preventive effects of myrtenol (MYR), fatty acid nanocarriers (FANC), and myrtenol-loaded FANC (MYR + FANC) on neurological disturbance, stroke volume, the levels of malondialdehyde (MDA), superoxide dismutase (SOD), and tumor necrosis factor-alpha (TNF-α) in the brain with ischemia-reperfusion injuries induced by middle cerebral artery occlusion (MCAO) in rats. Seventy two Wistar male rats were divided into six main groups. The groups were sham, ischemia-reperfusion group (MACO), MACO-MYR (50 mg/kg), MACO-FANC (50 and 100 mg/kg), and MACO-MYR + FANC (50 mg/kg). Stroke volume, neurological deficit scores, and the brain levels of MDA, SOD, and TNF-α were examined with TTC staining, observation, and ELISA, respectively. Pretreatment with MYR, FANC (100 mg/kg), and MYR + FANC reduced the neurological deficit score and cerebral infarction volume. MYR, FANC (100 mg/kg), and MYR + FANC pretreatment increased and decreased brain SOD and MDA levels compared to MACO group, respectively. The TNF-α level decreased in the MYR + FANC group compared to MCAO and MCAO-MYR groups in the brain. The use of FANC (100 mg/kg), MYR, and MYR + FANC has protective effects against oxidative stress and ischemia-reperfusion injury. FANC probably improve the bioavailability of MYR, as MYR+ FANC had more therapeutic effects on the reduction of ischemia-reperfusion injuries, inflammation, and oxidative stress. © 2024 John Wiley & Sons Ltd. DOI: 10.1111/cbdd.14633 PMID: 39317688 [Indexed for MEDLINE] 5. Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug 23. doi: 10.1007/s00210-024-03375-2. Online ahead of print. Myrtenol ameliorates inflammatory, oxidative, apoptotic, and hyperplasic effects of urethane-induced atypical adenomatous hyperplasia in the rat lung. Amiresmaili S(1), Rajizadeh MA(2), Jafari E(3), Bejeshk MA(1)(4), Salimi F(5), Moslemizadeh A(6), Najafipour H(7)(8). Author information: (1)Department of Physiology, Bam University of Medical Sciences, Bam, Iran. (2)Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. (3)Department of Pathology, Pathology and Stem Cell Research Center, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran. (4)Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran. (5)Department of Clinical Biochemistry, Medical Faculty, and Endocrinology and Metabolism Research Center, Kerman University of Medical Sciences, Kerman, Iran. (6)Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. (7)Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. najafipourh@yahoo.co.uk. (8)Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran. najafipourh@yahoo.co.uk. Lung atypical adenomatous hyperplasia (AAH) is a forerunner of pulmonary adenocarcinoma. The drugs being utilized in the remediation of this type of hyperplasia have some adverse impacts. The present research focused on the potential anti-hyperplasia effect of myrtenol, an herbal terpenoid, on urethane-induced lung AAH in rats. Rats were injected with urethane (1.5 g/kg) thrice at 48 h intervals, and 20 weeks later, the animals were treated with 50 mg/kg myrtenol intraperitoneally once a day for 1 week. The ELISA method was used to measure inflammatory cytokines and oxidative parameters in the lung tissue and bronchoalveolar lavage fluid (BALF). The expression of NFκB and apoptotic/antiapoptotic factors (P53/Bcl-2) was evaluated by western blot and immunohistochemistry, respectively. H&E staining was performed for histopathological investigation. Histopathology confirmed the anti-hyperplasia effect of myrtenol, which was evidenced by the reduction of bronchoalveolar wall thickness and inflammation score. It also decreased hyperplasia progression by reducing Bcl-2, IL-10, p53, and Ki67. Compared with the urethane group, myrtenol normalized the activity of the oxidative stress markers malondialdehyde (MDA), total antioxidant capacity (TAC), glutathione peroxidase (GPX), and superoxide dismutase (SOD). Moreover, it showed an anti-inflammatory effect by decreasing lung and BALF IL-1β levels and NFκB expression. Myrtenol may have a promising effect on lung cancer treatment by counteracting lung hyperplasia via modulation of inflammation, oxidative stress, and apoptosis. © 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. DOI: 10.1007/s00210-024-03375-2 PMID: 39177787